Search clinical trials for: GRF6019

Total 5 results

Alkahest, Inc.

Completed

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer Disease | Mild to Moderate Alzheimer Disease

United States
Alkahest, Inc.

Completed

A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease

Severe Alzheimer Disease

United States
Alkahest, Inc.

Completed

A Study to Evaluate the Effect of GRF6021 on Postoperative Recovery Following Primary Hip or Knee Arthroplasty

Postoperative Recovery

United States
Alkahest, Inc.
Michael J. Fox Foundation for Parkinson's Research

Completed

A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

Parkinson Disease

United States, France, Australia
Grünenthal GmbH

Terminated

A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain

Neuralgia

Germany, Hungary, Poland, United Kingdom

3

Subscribe